Purple Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.59	7.4	14.49	15.03	10.89	11.25
Short-Term Investments	0.86	1.12	0.92	17.08	36.31	46.56
Cash & Short-Term Investments	10.45	8.52	15.41	32.11	47.2	57.81
Cash Growth	65.94%	-44.69%	-52.01%	-31.96%	-18.35%	1215.24%
Accounts Receivable	-	-	-	-	-	0.5
Receivables	-	-	-	-	-	0.5
Prepaid Expenses	-	0.28	0.21	1	1.01	0.78
Other Current Assets	0.32	0.11	0.17	0.15	0.27	0.2
Total Current Assets	10.77	8.91	15.79	33.26	48.47	59.28
Property, Plant & Equipment	0.45	0.29	0.47	0.68	0.9	0.97
Long-Term Investments	-	-	-	-	0.19	-
Other Intangible Assets	27.84	27.84	28.04	20.68	20.48	20.48
Other Long-Term Assets	-	-	-	-	0.16	3.07
Total Assets	39.06	37.04	44.3	54.62	70.2	83.8
Accounts Payable	0.61	1.46	3.53	2.13	1.47	1.2
Accrued Expenses	1.17	1.2	3.46	4.72	2.56	1.69
Current Portion of Leases	0.21	0.18	0.19	0.19	0.2	0.21
Other Current Liabilities	4.07	1.15	2.52	0.01	0.02	-
Total Current Liabilities	6.06	3.99	9.7	7.06	4.25	3.1
Long-Term Leases	0.05	-	0.16	0.32	0.55	0.69
Pension & Post-Retirement Benefits	0.14	0.14	0.14	0.15	0.29	0.27
Total Liabilities	6.25	4.13	10.01	7.52	5.09	4.05
Additional Paid-In Capital	151.83	147.63	133.18	126.41	123.95	118.91
Retained Earnings	-147.53	-144.69	-137.45	-117.57	-95.91	-77.52
Comprehensive Income & Other	28.48	29.92	38.48	38.08	36.78	38
Total Common Equity	32.77	32.86	34.21	46.91	64.83	79.39
Minority Interest	0.04	0.05	0.09	0.19	0.28	0.36
Shareholders' Equity	32.82	32.91	34.3	47.1	65.11	79.75
Total Liabilities & Equity	39.06	37.04	44.3	54.62	70.2	83.8
Total Debt	0.26	0.18	0.35	0.52	0.75	0.9
Net Cash (Debt)	10.2	8.34	15.06	31.6	46.45	56.91
Net Cash Growth	67.78%	-44.62%	-52.34%	-31.98%	-18.38%	1264.09%
Net Cash Per Share	0.02	0.03	0.07	0.17	0.26	0.49
Filing Date Shares Outstanding	911.04	529.64	265.58	207.87	178.26	175.11
Total Common Shares Outstanding	911.04	517.13	252.38	184.82	178	172.11
Working Capital	4.72	4.92	6.09	26.2	44.22	56.18
Book Value Per Share	0.04	0.06	0.14	0.25	0.36	0.46
Tangible Book Value	4.93	5.02	6.16	26.23	44.35	58.91
Tangible Book Value Per Share	0.01	0.01	0.02	0.14	0.25	0.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.